The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
((1S,2S,4R)-4-((R)-1-(4-methoxyphenyl)ethylamino)-2-(thiophen-3-yl)cyclohexyl)(4-(5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)piperazin-1-yl)methanone ID: ALA1940366
PubChem CID: 57394808
Max Phase: Preclinical
Molecular Formula: C27H32F3N5O2S2
Molecular Weight: 579.71
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc([C@@H](C)N[C@@H]2CC[C@H](C(=O)N3CCN(c4nnc(C(F)(F)F)s4)CC3)[C@@H](c3ccsc3)C2)cc1
Standard InChI: InChI=1S/C27H32F3N5O2S2/c1-17(18-3-6-21(37-2)7-4-18)31-20-5-8-22(23(15-20)19-9-14-38-16-19)24(36)34-10-12-35(13-11-34)26-33-32-25(39-26)27(28,29)30/h3-4,6-7,9,14,16-17,20,22-23,31H,5,8,10-13,15H2,1-2H3/t17-,20-,22+,23-/m1/s1
Standard InChI Key: HOVSLXHXZHFJMS-ZZNFJVAJSA-N
Molfile:
RDKit 2D
39 43 0 0 0 0 0 0 0 0999 V2000
0.8708 0.1500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8708 -0.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5829 -1.0833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2949 -0.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2949 0.1500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5829 0.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0105 0.5604 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7238 0.1458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4395 0.5562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7214 -0.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1531 0.1359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8682 0.5457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8711 1.3715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1528 1.7860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4406 1.3739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5862 1.7829 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3000 1.3692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5824 -1.9086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9150 -2.3935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1700 -3.1782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9950 -3.1782 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.2498 -2.3935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1570 -1.0885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5581 -0.6771 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1582 -1.9135 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.5616 0.1512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2726 0.5626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9889 0.1525 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.9897 -0.6734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2742 -1.0894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7034 0.5709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7894 1.3934 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-3.5981 1.5705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0165 0.8559 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.4662 0.2374 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.9291 2.3262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4401 2.9906 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-4.7491 2.4174 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-4.3458 3.0458 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
8 10 1 1
3 4 1 0
19 20 2 0
20 21 1 0
21 22 1 0
22 18 2 0
3 18 1 6
9 11 2 0
2 23 1 1
4 5 1 0
23 24 1 0
11 12 1 0
23 25 2 0
24 26 1 0
5 6 1 0
12 13 2 0
13 14 1 0
5 7 1 1
24 30 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
14 15 2 0
28 31 1 0
31 32 1 0
15 9 1 0
1 2 1 0
13 16 1 0
7 8 1 0
32 33 1 0
33 34 2 0
34 35 1 0
35 31 2 0
16 17 1 0
33 36 1 0
18 19 1 0
36 37 1 0
1 6 1 0
36 38 1 0
8 9 1 0
36 39 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 579.71Molecular Weight (Monoisotopic): 579.1950AlogP: 5.58#Rotatable Bonds: 7Polar Surface Area: 70.59Molecular Species: BASEHBA: 8HBD: 1#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 9.51CX LogP: 5.11CX LogD: 3.02Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.39Np Likeness Score: -1.48
References 1. Anthony Romero F, Hastings NB, Moningka R, Guo Z, Wang M, Di Salvo J, Lei Y, Trusca D, Deng Q, Tong V, Terebetski JL, Ball RG, Ujjainwalla F.. (2012) The discovery of potent antagonists of NPBWR1 (GPR7)., 22 (2): [PMID:22197390 ] [10.1016/j.bmcl.2011.11.126 ]